Mutual inhibition through hybrid oligomer formation of daptomycin and the semisynthetic lipopeptide antibiotic CB-182,462

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 2, 2013, Pages 302-308

  Zhang, Tianhua ^a   Muraih, Jawad K ^a   Mintzer, Evan ^b   Tishbi, Nasim ^b   Desert, Celine ^c   Silverman, Jared ^d   Taylor, Scott ^a   Palmer, Michael ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b YESHIVA UNIVERSITY   (United States)

^c UNIV RENNES   (France)

^d CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

A54145; Daptomycin; Fluorescence; Lipopeptide antibiotics; Oligomerization

Indexed keywords

CB 182462; DAPTOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL MEMBRANE; DRUG INHIBITION; EXCIMER FLUORESCENCE; FLUORESCENCE; FLUORESCENCE ENERGY TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BENZYLIDENE COMPOUNDS; CALORIMETRY; CELL MEMBRANE; DAPTOMYCIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG DESIGN; LIPOPEPTIDES; LIPOPROTEINS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MORPHINANS; PERYLENE; PHOSPHATIDYLGLYCEROLS; SPECTROMETRY, FLUORESCENCE;

BACILLUS SUBTILIS; POSIBACTERIA;

EID: 84870182346     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2012.10.008     Document Type: Article

References (30)

1. J.M. Bell, J.D. Turnidge, H.S. Sader, and R.N. Jones Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008) Pathology 42 2010 470 473
2. R. Cantón, P. Ruiz-Garbajosa, R.L. Chaves, and A.P. Johnson A potential role for daptomycin in enterococcal infections: what is the evidence? J. Antimicrob. Chemother. 65 2010 1126 1136
3. F.P. Tally, M. Zeckel, M.M. Wasilewski, C. Carini, C.L. Berman, G.L. Drusano, and F.B. Oleson Daptomycin: a novel agent for Gram-positive infections Expert Opin. Investig. Drugs 8 1999 1223 1238
4. W.E.J. Alborn, N.E. Allen, and D.A. Preston Daptomycin disrupts membrane potential in growing Staphylococcus aureus Antimicrob. Agents Chemother. 35 1991 2282 2287
5. J.A. Silverman, N.G. Perlmutter, and H.M. Shapiro Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus Antimicrob. Agents Chemother. 47 2003 2538 2544
6. N. Cotroneo, R. Harris, N. Perlmutter, T. Beveridge, and J.A. Silverman Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus Antimicrob. Agents Chemother. 52 2008 2223 2225
7. N.E. Allen, W.E.J. Alborn, and J.N.J. Hobbs Inhibition of membrane potential-dependent amino acid transport by daptomycin Antimicrob. Agents Chemother. 35 1991 2639 2642
8. J.K. Muraih, A. Pearson, J. Silverman, and M. Palmer Oligomerization of daptomycin on membranes Biochim. Biophys. Acta 1808 2011 1154 1160
9. J.K. Muraih, J. Harris, S. Taylor, and M. Palmer Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation Biochim. Biophys. Acta 1818 2012 673 678
10. M. Debono, M. Barnhart, C.B. Carrell, J.A. Hoffmann, J.L. Occolowitz, B.J. Abbott, D.S. Fukuda, R.L. Hamill, K. Biemann, and W.C. Herlihy A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation J. Antibiot. (Tokyo) 40 1987 761 777
11. L.D. Boeck, H.R. Papiska, R.W. Wetzel, J.S. Mynderse, D.S. Fukuda, F.P. Mertz, and D.M. Berry A54145, a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC J. Antibiot. (Tokyo) 43 1990 587 593
12. C. Mascio, K. Townsend, N. Cotroneo, and J. Silverman Microbiological Characterization of a Novel Lipopeptide Antibiotic with Activity in Pulmonary Surfactant. (Conference presentation, ICAAC 2009.) 2009
13. H. Heerklotz, A.D. Tsamaloukas, and S. Keller Monitoring detergent-mediated solubilization and reconstitution of lipid membranes by isothermal titration calorimetry Nat. Protoc. 4 2009 686 697
14. J.K. Muraih, and M. Palmer Estimation of the subunit stoichiometry of the membrane-associated daptomycin oligomer by FRET Biochim. Biophys. Acta 1818 2012 1642 1647
15. D. Lancet, and I. Pecht Spectroscopic and immunochemical studies with nitrobenzoxadiazolealanine, a fluorescent dinitrophenyl analogue Biochemistry 16 1977 5150 5157
16. R.S. Brown, J.D. Brennan, and U.J. Krull Self-quenching of nitrobenzoxadiazole labeled phospholipids in lipid membranes J. Chem. Phys. 100 1994 6019 6027
17. J.H. Lakey, and M. Ptak Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes Biochemistry 27 1988 4639 4645
18. P.K. Gessner Isobolographic analysis of interactions: an update on applications and utility Toxicology 105 1995 161 179
19. R. Jursch, A. Hildebrand, G. Hobom, J. Tranum-Jensen, R. Ward, M. Kehoe, and S. Bhakdi Histidine residues near the N terminus of staphylococcal alpha-toxin as reporters of regions that are critical for oligomerization and pore formation Infect. Immun. 62 1994 2249 2256
20. B. Walker, O. Braha, S. Cheley, and H. Bayley An intermediate in the assembly of a pore-forming protein trapped with a genetically-engineered switch Chem. Biol. 2 1995 99 105
21. C.J. Miller, J.L. Elliott, and R.J. Collier Anthrax protective antigen: prepore-to-pore conversion Biochemistry 38 1999 10,432 10,441
22. E. Hotze, E. Wilson-Kubalek, J. Rossjohn, M. Parker, A. Johnson, and R. Tweten Arresting pore formation of a cholesterol-dependent cytolysin by disulphide trapping synchonizes the insertion of the transmembrane beta-sheet from a pre-pore intermediate J. Biol. Chem. 276 2001 8261 8268
23. K.T. Nguyen, X. He, D.C. Alexander, C. Li, J. Gu, C. Mascio, A.V. Praagh, L. Mortin, M. Chu, J.A. Silverman, P. Brian, and R.H. Baltz Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties Antimicrob. Agents Chemother. 54 2010 1404 1413
24. M. Strieker, and M.A. Marahiel The structural diversity of acidic lipopeptide antibiotics ChemBioChem 10 2009 607 616
25. N.N. Mishra, J. McKinnell, M.R. Yeaman, A. Rubio, C.C. Nast, L. Chen, B.N. Kreiswirth, and A.S. Bayer In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates Antimicrob. Agents Chemother. 55 2011 4012 4018
26. S.K. Straus, and R.E.W. Hancock Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides Biochim. Biophys. Acta 1758 2006 1215 1223
27. D.S. Cafiso Alamethicin: a peptide model for voltage gating and protein-membrane interactions Annu. Rev. Biophys. Biomol. Struct. 23 1994 141 165
28. Y. Shai Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim. Biophys. Acta 1462 1999 55 70
29. Y. Shai Mode of action of membrane active antimicrobial peptides Biopolymers 66 2002 236 248
30. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 2005 238 250